SCHEMBL31489688

SCHEMBL31489688

Cc1nn(C(c2ccc(F)cc2)C(C)(F)F)cc1-c1cncc(-c2ccn3nc(N)nc3c2)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 15/20 0.42
PIK3CD O00329 11/20 0.42
PAK4 O96013 1/20 0.40
JAK1 P23458 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
CSNK1A1 P48729 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
PIP4K2C Q8TBX8 1/20 0.40
CSNK1G1 Q9HCP0 1/20 0.40
RIPK1 Q13546 1/20 0.34
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30
CCNT1 O60563 1/20 0.30
CDK9 P50750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489187 1.00 PIK3CG (0.42) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489631 0.91 RIPK1 (0.38) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489319 0.91 RIPK1 (0.38) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489348 0.89 PIK3CG (0.40) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489251 0.88 PIK3CG (0.39) PIK3CGPIK3CDPIK3CAPIK3CBKDM4E
SCHEMBL31489619 0.88 PIK3CG (0.36) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489943 0.88 PIK3CG (0.36) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489252 0.87 PIK3CG (0.43) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489624 0.87 PIK3CG (0.43) PIK3CGPIK3CDPAK4JAK1PIK3CA
SCHEMBL31489707 0.87 PIK3CG (0.34) PIK3CGPIK3CDPAK4JAK1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed